...
机译:预测移植物与宿主疾病的危险因素,同种异体造血干细胞移植在复发或难治性非霍奇金淋巴瘤中进行复发存活
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Catholic Univ Korea Seoul St Marys Hosp Catholic Hematol Hosp Coll Med Div Lymphoma Myeloma 505;
Allogeneic hematopoietic stem cell transplantation; Endpoint; Graft-versus-host disease; Lymphoma;
机译:预测移植物与宿主疾病的危险因素,同种异体造血干细胞移植在复发或难治性非霍奇金淋巴瘤中进行复发存活
机译:预测接受造血干细胞移植的复发/难治性非霍奇金淋巴瘤的儿科患者存活的危险因素:土耳其小儿骨髓移植登记处的回顾性研究
机译:成人同种异体造血干细胞移植后的移植物与宿主无病和复发存活的预后因素
机译:循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
机译:异基因造血干细胞移植后慢性移植物抗宿主病患者的症状,细胞因子和生活质量。
机译:异基因造血干细胞移植后复发或难治性非霍奇金淋巴瘤的预测移植物抗宿主病和无复发生存的危险因素
机译:预测移植物与宿主疾病的危险因素,同种异体造血干细胞移植在复发或难治性非霍奇金淋巴瘤中进行复发存活